bms-844203
Recombinant proteinexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2006 (NCT00374179)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- bms-844203
- bms-844203
- ct-322
- ct-322
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01146171 | Phase 1 | Nov 1, 2013 | Bristol-Myers Squibb |
| NCT00851045 | Phase 2 | Oct 1, 2009 | Bristol-Myers Squibb |
| NCT00850577 | Phase 2 | Jun 1, 2009 | Bristol-Myers Squibb |
| NCT00768911 | Phase 1 | Oct 1, 2008 | Bristol-Myers Squibb |
| NCT00562419 | Phase 2 | Oct 1, 2007 | Bristol-Myers Squibb |
| NCT00374179 | Phase 1 | Aug 1, 2006 | Bristol-Myers Squibb |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bristol-Myers Squibb | For profit | 6 | 6 | 2 | 2006 |
1 organizations
Page 1 / 1